Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HLN · against 66 other Healthcare companies of similar size
Ranked #58 of 67 · scores higher than 14% of peers
Bars: peers in each 10-point band of the growth score3 peers with a growth score of 30–39, including HLN · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | HLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 68 reported | -1.8% | 11.9% | 3% | 33% | |
| Earnings per share growthHigher is better · 51 reported | 17.3% | 14.8% | 56% | 33% | |
| 3-year revenue growthHigher is better · 67 reported | 0.5% | 9.0% | 15% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 21.4B USD | 97 | 67 | |
| 2 | 56.7B USD | 96 | 79 | |
| 3 | 22.8B USD | 95 | 38 | |
| 4 | 40.2B USD | 92 | 73 | |
| 5 | 4.61T JPY (≈$31.3B) | 89 | 76 | |
| 53 | 34.3B USD | 42 | 57 | |
| 55 | 54.9B USD | 40 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 59 |
| 56 | 36.4B USD | 39 | 50 |
| 57 | 38.4B USD | 38 | 50 |
| 58 | 38.9B USD | 36 | 56 |
| 59 | 64.8B EUR (≈$71.3B) | 29 | 51 |
| 60 | 154.4B BRL (≈$27.8B) | 28 | 43 |
| 61 | 36.0B USD | 27 | 46 |
| 62 | 21.7B USD | 26 | 32 |